| Presentor(s) |
M. Santini, Rome (IT) |
| Episode |
20 |
| Year |
2008 |
| Duration |
14:37 |
Shownotes "The existing evidence on the effect of telemonitoring on all-cause mortality together with the correlations identified in the MIDHeFT trial between changes in intrathoracic impedance and impending HF hospitalisations have justified the interest of a few Italian centers in evaluating the potential of the Medtronic CareLink
TM Network for the management of HF patients." Prof. Santini, member of the investigator group, reports the successes obtained during the pilot experience drawing interesting conclusions on ease of use of the system, as well as on efficiency in managing HF patients, through the use of specific clinical cases tracked during the evaluation period."
